Company Profile

Eintering a new age in understanding of the interaction between cells and their surrounding tissue, Halo bBosciencers is enabling discovery of new therapeutic targets for inflammation and fibrosis. The Halo approach focuses on inhibition of a critical cell-tissue mediator that is sregulated in the context of inflammatory and fibrotic disease - Hyaluronan (HA). % The work so far undertaken has shown that inhibiting the synthesis of HA has the potential safely to down-regulate various inflammatory and fibrotic cell-signaling pathways awhile also driving clinical outcomes in diseases like pulmonary hypertension and pulmonary fibrosis.